About Editas Medicine
Editas Medicine Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes.
Company details
Funding
Total raised
$210M
Last stage
Public
Investors
Founders
George Church
Harvard geneticist and genome engineering pioneer; co-founded Editas Medicine in 2013.
David R. Liu
Harvard University/Howard Hughes Medical Institute scientist; world leader in genome editing and base editing technologies.
Feng Zhang
Researcher at the MIT-Harvard Broad Institute; one of the pioneers of CRISPR-Cas9 gene editing in eukaryotic cells.
LinkedInJennifer Doudna
Professor at UC Berkeley and Nobel Laureate (2020); co-inventor of CRISPR-Cas9 gene editing technology.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.